New diagnostic methods for tuberculosis
FEND for TB
This study is working on new ways to diagnose tuberculosis more accurately, especially for people who might have other health issues or drug-resistant TB, and it's looking for patients in places like India and Peru to help test these tools in real-life situations.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10848342 on NIH RePORTER |
What this research studies
This research focuses on developing and testing novel diagnostic tools for tuberculosis (TB) in areas where the disease is prevalent. The project involves a collaboration of experienced researchers and clinical sites, particularly in India and Peru, to enhance the accuracy of TB diagnosis, especially for patients with co-morbidities and drug resistance. By utilizing advanced technologies and mathematical modeling, the research aims to identify effective diagnostic strategies that can be implemented in TB-endemic regions. Patients may be enrolled to evaluate these new diagnostics in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals of all ages living in TB-endemic areas, particularly those with co-morbidities or drug-resistant TB.
Not a fit: Patients who do not live in TB-endemic regions or those without tuberculosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of tuberculosis, improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown success in developing diagnostic tools for TB, but this approach aims to innovate further in a targeted manner.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Ellner, Jerrold J. — Rutgers Biomedical and Health Sciences
- Study coordinator: Ellner, Jerrold J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.